Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ressler

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
FEMS Microbiology Letters|July 1, 1996
Cellular transformation by human T-cell leukemia virus type IS Ressler, L M Connor, S J Marriott
Journal of Virology|February 1, 1997
Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoterS Ressler, G F Morris, S J Marriott
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2009
Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot studyR Greil, M Moik, R Reitsamer, et al.
Academic Pediatrics|December 28, 2020
Incomplete Records as a Leading Cause of Missed Opportunity for Human Papillomavirus Vaccine Initiation in a Safety Net Health SystemLindy U McGee, Kelly S Ressler, Julie A Boom, et al.
Journal of Virology|October 19, 2007
WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infectionR Alvarez, J Reading, D F L King, et al.
Experimental Gerontology|April 22, 2006
Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescenceB Hampel, K Fortschegger, S Ressler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)G G Steger, R Greil, A Lang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy aloneM Gnant, M Filipits, R Greil, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
FEMS Microbiology Letters|July 1, 1996
Cellular transformation by human T-cell leukemia virus type IS Ressler, L M Connor, S J Marriott
Journal of Virology|February 1, 1997
Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoterS Ressler, G F Morris, S J Marriott
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 3, 2009
Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot studyR Greil, M Moik, R Reitsamer, et al.
Academic Pediatrics|December 28, 2020
Incomplete Records as a Leading Cause of Missed Opportunity for Human Papillomavirus Vaccine Initiation in a Safety Net Health SystemLindy U McGee, Kelly S Ressler, Julie A Boom, et al.
Journal of Virology|October 19, 2007
WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infectionR Alvarez, J Reading, D F L King, et al.
Experimental Gerontology|April 22, 2006
Increased expression of extracellular proteins as a hallmark of human endothelial cell in vitro senescenceB Hampel, K Fortschegger, S Ressler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)G G Steger, R Greil, A Lang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy aloneM Gnant, M Filipits, R Greil, et al.
Pageof 1